Researchers seek FDA approval for diabetes cell transplants

05/14/2013 | Denver Post, The

A consortium led by the University of Minnesota is preparing to seek FDA approval of a potential breakthrough treatment for type 1 diabetes that involves transplanting insulin-producing islet cells. Clinical studies have demonstrated that 60% to 70% of patients receiving the transplants remained insulin-free after five years. Approximately 1.5 million Americans have type 1 diabetes, in which the body destroys its own islet cells.

View Full Article in:

Denver Post, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ